Trump signs healthcare executive order that includes a win for pharma companies | The Business Standard
Skip to main content
  • Latest
  • Epaper
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Wednesday
June 18, 2025

Sign In
Subscribe
  • Latest
  • Epaper
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
WEDNESDAY, JUNE 18, 2025
Trump signs healthcare executive order that includes a win for pharma companies

USA

Reuters
16 April, 2025, 11:55 am
Last modified: 16 April, 2025, 03:26 pm

Related News

  • Israel airstrikes target Iranian missile facilities, Trump calls for Tehran's 'unconditional surrender'
  • Japan PM Ishiba says disagreements remain with US on tariff talks
  • Trump to host Pakistan’s Chief of Army Staff at White House
  • 'Not going to kill Khamenei, at least for now', says Trump, claiming US knows Iran's supreme leader's location
  • 'Not a ceasefire': Trump seeking 'real end' to Israel-Iran conflict

Trump signs healthcare executive order that includes a win for pharma companies

Drugmakers have been pushing to delay the timeline under which medications become eligible for price negotiations by four years for small molecule drugs, which are primarily pills and account for most medicines

Reuters
16 April, 2025, 11:55 am
Last modified: 16 April, 2025, 03:26 pm
US President Donald Trump reacts as he meets NATO Secretary General Mark Rutte (not pictured), in the Oval Office at the White House in Washington, DC, US, March 13, 2025. Photo: REUTERS/Evelyn Hockstein/File Photo
US President Donald Trump reacts as he meets NATO Secretary General Mark Rutte (not pictured), in the Oval Office at the White House in Washington, DC, US, March 13, 2025. Photo: REUTERS/Evelyn Hockstein/File Photo

Highlights:

  • Trump's order targets Medicare drug price negotiation timeline
  • Congress must approve changes to Medicare price negotiations
  • Order encourages state drug importation programs
  • FDA urged to streamline approval for generics and biosimilars

US President Donald Trump directed his health department on Tuesday to work with Congress on revamping a law that allows Medicare to negotiate prescription drug prices, seeking to introduce a change the pharmaceutical industry has lobbied for.

Drugmakers have been pushing to delay the timeline under which medications become eligible for price negotiations by four years for small molecule drugs, which are primarily pills and account for most medicines.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

That would align with the 13-year wait until more complex biotech drugs become eligible for Medicare price negotiations.

The wide-ranging executive order signed by Trump aims to reduce healthcare costs. It comes one day after the Trump administration instituted a national security report into the pharmaceutical industry, a precursor to sector-specific tariffs.

The ability of Medicare for the first time to directly negotiate prices on selected medicines was part of President Joe Biden's Inflation Reduction Act. Medicare covers 66 million Americans, mostly aged 65 and older.

Drugmakers have complained about the terms of Medicare's negotiating powers, saying it would stifle innovation. In particular, the industry has opposed the time frame for negotiation eligibility for most drugs.

When drugs have no competition, the law now allows the government to negotiate prices for complex biologic, or biotech, drugs after 13 years on the market, but after 9 years for drugs taken as pills and capsules.

Trump cannot implement the change through executive order because the negotiation process is outlined in legislation, but his order instructs Secretary of Health and Human Services Robert F. Kennedy Jr. to work with Congress on changing it.

Other proposed changes to the negotiation process would yield more savings than those achieved during the first round under the Biden administration, White House officials told reporters on a call before the signing without providing specifics.

Biden's administration had negotiated a price cut of as much as 79% for the first group of 10 drugs seen as among the most costly to the Medicare program.

The Trump administration will negotiate prices for the second group of 15 medications, which includes Novo Nordisk's blockbuster diabetes and weight-loss treatments Ozempic and Wegovy as well as Pfizer's cancer drugs Ibrance and Xtandi.

Trump's order also seeks to align Medicare payments for drugs with those of hospitals, which can be 35% lower, and calls for standardizing patient payment rates across locations so that people are not charged different rates depending on where they receive care, a policy known as site-neutral payments.

Trump directed the Food and Drug Administration to encourage more applications from states for drug importation programs, which were initiated during his first term.

So far only Florida has won FDA authorization to directly import drugs from Canada, even though several more states have applied. It also directs the FDA to streamline approval for less expensive generic and biosimilar versions of branded medicines.

Top News / World+Biz

Donald Trump / Trump Tariffs / Trump Trade War / Pharma industry

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Donald Trump speaks to members of the media on the South Lawn at the White House in Washington, DC, 18 June 2025. Photo: Reuters
    'I may do it, I may not': Trump on US joining Israeli strikes on Iran
  • Evacuation of Bangladeshis: Where do they go next from conflict-ridden Iran?
    Evacuation of Bangladeshis: Where do they go next from conflict-ridden Iran?
  • Iran's Supreme Leader Ayatollah Ali Khamenei speaks during a meeting with the members of the Expediency Discernment Council in Tehran, Iran October 12, 2022. File Photo: Office of the Iranian Supreme Leader/WANA (West Asia News Agency)/Handout via REUTERS
    Khamenei says any US strikes will have serious consequences, rejects Trump's call for surrender

MOST VIEWED

  • Infograph: TBS
    Govt to ease loan rules to help foreign firms expand in Bangladesh
  • Google Pay. Photo: Collected
    Google Pay coming to Bangladesh next week
  • Logo of Beximco Group. Photo: Collected
    Beximco defaults on €33m in Germany, Deshbandhu owes Czech bank €4m
  • Global map showing nuclear weapon inventories by country as of January 2025, including deployed, stored, and retired warheads. Source: SIPRI
    How Israel's secret nuclear arsenal comes under spotlight amid attacks on Iran
  • The Kallyanpur Canal is burdened with more than 600,000 kilograms of waste every month. Photo: Courtesy
    Kallyanpur canal project shows how to combat plastic pollution in Dhaka
  • The India-Bangladesh integrated checkpost in Fulbari. Photo: Passang Yolmo via Telegraph India
    Import of boulders from Bhutan to Bangladesh stopped by Indian transporters in Fulbari

Related News

  • Israel airstrikes target Iranian missile facilities, Trump calls for Tehran's 'unconditional surrender'
  • Japan PM Ishiba says disagreements remain with US on tariff talks
  • Trump to host Pakistan’s Chief of Army Staff at White House
  • 'Not going to kill Khamenei, at least for now', says Trump, claiming US knows Iran's supreme leader's location
  • 'Not a ceasefire': Trump seeking 'real end' to Israel-Iran conflict

Features

Evacuation of Bangladeshis: Where do they go next from conflict-ridden Iran?

Evacuation of Bangladeshis: Where do they go next from conflict-ridden Iran?

11m | Panorama
The Kallyanpur Canal is burdened with more than 600,000 kilograms of waste every month. Photo: Courtesy

Kallyanpur canal project shows how to combat plastic pollution in Dhaka

1d | Panorama
The GLS600 overall has a curvaceous nature, with seamless blends across every panel. PHOTO: Arfin Kazi

Mercedes Maybach GLS600: Definitive Luxury

2d | Wheels
Renowned authors Imdadul Haque Milon, Mohit Kamal, and poet–children’s writer Rashed Rouf seen at Current Book Centre, alongside the store's proprietor, Shahin. Photo: Collected

From ‘Screen and Culture’ to ‘Current Book House’: Chattogram’s oldest surviving bookstore

3d | Panorama

More Videos from TBS

What's going on in Netanyahu's head behind the regime change story?

What's going on in Netanyahu's head behind the regime change story?

11m | TBS World
The type of bomb the US could use if Trump attacks Iran

The type of bomb the US could use if Trump attacks Iran

41m | TBS World
Why is Fordow Nuclear Facility at the Center of Trump’s Deliberations?

Why is Fordow Nuclear Facility at the Center of Trump’s Deliberations?

2h | TBS World
AI will replace jobs at tech giant: Amazon CEO

AI will replace jobs at tech giant: Amazon CEO

3h | Others
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net